Application Information for Hollis Brownstein Research Grants Program

FUNDING CYCLE AND DUE DATES

Hollis Brownstein Research Grants Program

2020-2021 Funding Cycle

  • Grant period is one year (July 1, 2020 – June 30, 2021)
  • Grant awards up to $100,000

February 7, 2020 - Letter of Intent Due

By March 2, 2020 - Notification if invited to submit Full Application

March 30, 2020 - Full Application due (if invited to submit)

June 30, 2020 - Grant recipients notified of award

ELIGIBILITY

  • The Leukemia Research Foundation exclusively funds New Investigator grants for blood cancer research projects that focus on leukemia, lymphoma, multiple myeloma, and/or MDS.
  • New Investigators are considered to be within seven (7) years of their first independent position. Years as a resident physician, fellow physician, or post-doctoral fellow are considered to be training years.
  • Adjustments for career interruptions can be made. These could include, but are not limited to, family leave, military service, major illness or injury. It is the responsibility of the applicant to point out and document such interruptions.
  • Applicants are not required to be U.S. citizens and research projects from outside the U.S. are eligible.
  • Applicants with an NIH KO8 or K23 are eligible.
  • DOE, DOD, NSF, R21, or other grants with less than $175,000 per year in total direct costs are permitted.

Exclusions:

  • Any single grant of $175,000 or greater in total direct costs per year.
  • Multiple grants which, when added together, have a total of $175,000 or more per year in total direct costs.
  • NIH RO1 funding, VA Merit Award or equivalent.
  • Career development awards from other national foundations (ACS, ASH, Burroughs Wellcome, Kimmel Scholar, etc.).
  • Renewal applications will not be accepted.

Minority applicants are valued members of the research community, vital to its success, and are encouraged to apply.

If you have questions about eligibility, please email Grants@LRFmail.org.

LETTERS OF INTENT

A Letter of Intent allows the Leukemia Research Foundation to quickly assess if there is a good match between LRF's goals and the project. If it appears to be a good match, we will invite you to submit a full application.

The LOI deadline for the 2020-2021 funding cycle is February 7, 2020.

If you are invited to submit a full application, you will be notified by March 2, 2020. Full application guidelines and forms will be sent to you if you are invited to apply.

LOI Requirements

Letters of Intent are generally 2–3 pages. The cover sheet, biosketch and budget are not included in the suggested 2-3 page limit.

Please follow this format:
Include a cover sheet with the LOI (click here)
All submissions are required to be in one pdf document titled Last Name, First Name, Middle Initial

  1. Abstract (not to exceed 250 words)
    • The abstract is the most important component of the LOI. Spend time developing the best possible title.
    • Use bold subheadings. Include highlights in the topic sentence in each section of the LOI.
    • What will be done, by whom, how, over what period of time? What is the problem/need? Who will the outcomes benefit?
  2. Statement of Need: The "why" of the project. (1–2 paragraphs)
    • What is the issue that you are addressing and why does it matter?
    • Why is what you propose necessary? What is the void in knowledge?
    • Who benefits? Indicate the public good, not just the effect on campus.
    • Why hasn't this issue been addressed sufficiently in the past? Who else is working in this field, what have they done, and why isn't that enough? Demonstrate your knowledge of the field.
    • Provide convincing evidence that what you are proposing does not duplicate other work. Replication of someone else's work in a new environment or larger scale may be fundable.
  3. Project Activity: The "what" and "how" of the project. (The bulk of your LOI)
    • Why did you choose to address the issue in the manner that you have? Are there other approaches? If so, why aren't they appropriate to the situation?
    • What are the specific activities involved? Who will do them?
    • Present a timeline of activities. Tables and charts work best here. They crystallize data, break up pages of narrative, and convey extensive information well in a limited space.
    • What specific outcomes will be achieved? What will change?
    • Why are you/your organization the best one to do what you propose to do? Is it an extension of successful, innovative work or a pilot project you already completed?
  4. Outcomes/Evaluation (1–2 paragraphs; before or after the Project Activity)
    • Essential piece that should be both quantitative and qualitative, if feasible.
    • Outline clearly the methodology that you will use to assess the project’s success.
  5. Credentials (NIH biosketch)
  6. Budget
  7. Current and pending grant support- include the project name/topic, funding agency, grant period, funding amount, and status of funding.
  8. Closing (1 paragraph)
  9. Signature of applicant
  10. Email completed LOI to Grants@LRFmail.org
FUNDING GUIDELINES

  • The Leukemia Research Foundation does not provide funds for capital equipment (i.e. equipment purchases in excess of $5,000). Any request for exception to this policy must detail clearly the specific need of the capital equipment for the proposed research project.
  • The Leukemia Research Foundation does not provide salary support for the principal investigator.
  • Using funds for research travel is permitted but should not exceed $1,000. This money is intended only to enhance the study.
  • All other support for the project must be clearly detailed including all sources for the requested and related projects. Clearly indicate funding overlap.
  • All previous support from the Leukemia Research Foundation must be clearly stated; please list the title of the project, period(s) of support, and amount of award.
  • The Leukemia Research Foundation does not provide indirect cost recovery or institutional overhead costs.
FORMAT AND SUBMISSION GUIDELINES

  • Submissions are required to be in one pdf document titled Last Name, First Name, Middle Initial.
  • Document format should be single spaced with a 12 point font used throughout. The paper size should be 8 1/2 inches by 11 inches.
  • Your PDF file cannot exceed 10 MB in size. If it is larger than 10 MB please make arrangements with the Research Grants Administrator to accept it.
  • You must use the 2020-2021 LOI cover sheet. This form must be filled out in its entirety for a proposal to be accepted and assigned for review.
  • Submissions should be e-mailed to: Grants@LRFMail.org. All applicants will receive a receipt via e-mail when their submission is received.
  • Submissions will only be accepted electronically; hard copies will not be accepted.
  • Incomplete submissions will not be accepted.
FULL APPLICATION INFORMATION

  • After the LOI review, you will be notified if you are invited to submit a Full Application by March 2, 2020.
  • If you are invited to submit a Full Application, you will receive the Full Application documents and guidelines via email.
  • The Full Application will be due March 30, 2020.
NOTIFICATION OF RESULTS

All Full Applications for the 2020-2021 funding cycle will be reviewed by the Leukemia Research Foundation's independent Medical Advisory Board in early June. The Foundation approves applications for funding based on the recommendation of this panel. Notification will be e-mailed to applicants on June 30, 2020. Results will not be available prior to this date. Leukemia Research Foundation reviewers do not prepare written reviews.

DOWNLOAD THE REQUIRED FORMS

LOI Cover Sheet [PDF] [Word]

NIH Biosketch [Word]

Budget [Word]

QUESTIONS

If you have questions, please email the Director of Programs/Research Grants Administrator at Grants@lLRFmail.org.